RU2009141845A - Способы и композиции для содействия в лечении злокачественных опухолей - Google Patents

Способы и композиции для содействия в лечении злокачественных опухолей Download PDF

Info

Publication number
RU2009141845A
RU2009141845A RU2009141845/15A RU2009141845A RU2009141845A RU 2009141845 A RU2009141845 A RU 2009141845A RU 2009141845/15 A RU2009141845/15 A RU 2009141845/15A RU 2009141845 A RU2009141845 A RU 2009141845A RU 2009141845 A RU2009141845 A RU 2009141845A
Authority
RU
Russia
Prior art keywords
tumor
chemotherapeutic agent
agonist
specified
interferon
Prior art date
Application number
RU2009141845/15A
Other languages
English (en)
Russian (ru)
Inventor
Анил ГУЛАТИ (US)
Анил ГУЛАТИ
Редди ГУРУ (US)
Редди ГУРУ
Луиджи ЛЕНАЗ (US)
Луиджи ЛЕНАЗ
Original Assignee
Спектрум Фармасьютикалз, Инк. (Us)
Спектрум Фармасьютикалз, Инк.
Дзе Борд Оф Трастиз Оф Дзе Юниверсити Оф Иллинойс (Us)
Дзе Борд Оф Трастиз Оф Дзе Юниверсити Оф Иллинойс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Спектрум Фармасьютикалз, Инк. (Us), Спектрум Фармасьютикалз, Инк., Дзе Борд Оф Трастиз Оф Дзе Юниверсити Оф Иллинойс (Us), Дзе Борд Оф Трастиз Оф Дзе Юниверсити Оф Иллинойс filed Critical Спектрум Фармасьютикалз, Инк. (Us)
Publication of RU2009141845A publication Critical patent/RU2009141845A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2285—Endothelin, vasoactive intestinal contractor [VIC]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RU2009141845/15A 2007-04-13 2008-04-10 Способы и композиции для содействия в лечении злокачественных опухолей RU2009141845A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91177307P 2007-04-13 2007-04-13
US60/911,773 2007-04-13

Publications (1)

Publication Number Publication Date
RU2009141845A true RU2009141845A (ru) 2011-05-20

Family

ID=39521878

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2009141845/15A RU2009141845A (ru) 2007-04-13 2008-04-10 Способы и композиции для содействия в лечении злокачественных опухолей

Country Status (15)

Country Link
EP (1) EP2144607B1 (https=)
JP (1) JP5503528B2 (https=)
KR (1) KR20100016392A (https=)
CN (1) CN101686960A (https=)
AR (1) AR066048A1 (https=)
BR (1) BRPI0810215A2 (https=)
CA (1) CA2683890C (https=)
DK (1) DK2144607T3 (https=)
ES (1) ES2453295T3 (https=)
IL (1) IL201502A (https=)
MX (1) MX2009011041A (https=)
RU (1) RU2009141845A (https=)
TW (1) TWI439266B (https=)
WO (1) WO2008127996A1 (https=)
ZA (1) ZA200907083B (https=)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2502848C (en) * 2002-10-24 2012-10-02 The Board Of Trustees Of The University Of Illinois Use of irl-1620 and paclitaxel for preventing and treating breast tumors
CA2598439A1 (en) * 2005-02-22 2006-08-31 The Board Of Trustees Of The University Of Illinois Methods, compositions and articles of manufacture for contributing to the treatment of solid tumors

Also Published As

Publication number Publication date
KR20100016392A (ko) 2010-02-12
IL201502A (en) 2017-01-31
TWI439266B (zh) 2014-06-01
ES2453295T3 (es) 2014-04-07
EP2144607A1 (en) 2010-01-20
AR066048A1 (es) 2009-07-22
WO2008127996A1 (en) 2008-10-23
JP2010523697A (ja) 2010-07-15
BRPI0810215A2 (pt) 2014-10-21
ZA200907083B (en) 2011-01-26
CA2683890A1 (en) 2008-10-23
AU2008240300A1 (en) 2008-10-23
MX2009011041A (es) 2009-11-19
JP5503528B2 (ja) 2014-05-28
CA2683890C (en) 2020-01-07
IL201502A0 (en) 2010-05-31
DK2144607T3 (da) 2014-04-07
HK1140145A1 (en) 2010-10-08
EP2144607B1 (en) 2014-01-08
TW200904404A (en) 2009-02-01
CN101686960A (zh) 2010-03-31

Similar Documents

Publication Publication Date Title
Watters et al. Oral complications of targeted cancer therapies: a narrative literature review
RU2009107085A (ru) Способы, композиции и изделия, способствующие лечению рака
JP2010514787A5 (https=)
ES2282400T3 (es) Composiciones antitumorales que contienen derivados de taxano.
Zheng et al. Anti-cancer effect of rubropunctatin against human gastric carcinoma cells BGC-823
MX383644B (es) Combinaciones y metodos de administracion de agentes terapeuticos y terapia de combinacion.
RU2010117635A (ru) Комбинированная химиотерапия
PH12012500504A1 (en) N-(4-((3-(2-amino-4-pyrimidinyl)-2-pyridinyl)oxy)phenyl)-4-(4-methyl-2-thienyl)-1-phthalazinamine in the treatment of antimitotic agent resistent cancer
JP2009545609A5 (https=)
WO2009120697A4 (en) Method and compositions for treatment of cancer
JP2023024618A (ja) がんの処置のためのトランス－［テトラクロロビス（１ｈ－インダゾール）ルテネート（ｉｉｉ）］の使用
Kasper et al. Novel treatment strategies for soft tissue sarcoma
RU2009111605A (ru) Сенсибилизация опухолевых клеток к лучевой терапии посредством введения агонистов эндотелина
JP6707088B2 (ja) （１Ｅ，４Ｅ）−２−アミノ−Ｎ，Ｎ−ジプロピル−８−（４−（ピロリジン−１−カルボニル）フェニル）−３Ｈ−ベンゾ［ｂ］アゼピン−４−カルボキサミドを含む固体形態、その組成物、およびその使用
JP2016505043A5 (https=)
Uchida et al. Sequence-dependent antitumour efficacy of combination chemotherapy of nedaplatin, a novel platinum complex, with 5-fluorouracil in an in vivo murine tumour model
RU2009141845A (ru) Способы и композиции для содействия в лечении злокачественных опухолей
TW202039472A (zh) 作為組合醫藥使用之含有ezh1/2雙重抑制劑之醫藥組成物
CA2562756A1 (en) Methods for controlling angiogenesis and cell proliferation using a desulphatohirudin
RU2007102086A (ru) Химиотерапия рака
Ghanwatkar et al. Dual Inhibition of KRAS G12D and PI3K/BRD4 Signaling Overcomes Therapeutic Resistance in Pancreatic Cancer
US20090221628A1 (en) Compositions and methods for treatment of prostate and breast cancer
JP2007523123A5 (https=)
Roberts et al. Chemotherapy regimens for patients with newly diagnosed malignant bone tumors
JP2010523697A5 (https=)

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20121129